China’s Mass Testing Brings Big Profits to Makers of Virus Test-Kits

Residents get swabbed during mass COVID-19 testing in the Chaoyang District in Beijing on June 14, 2022. Andy Wong/AP Photo

China’s reliance on mass testing to achieve “zero-COVID” has brought huge profits to virus test-kit makers.

A number of biotech companies have reported substantial profit growth for the first half of 2022. Among them, Tianjin City’s Jiu'an Medical Electronics Co., Ltd. posted a net profit of over 15.1 billion yuan ($2.24 billion), an increase of 270 fold from the same period last year.